131 related articles for article (PubMed ID: 9200270)
1. The elimination of secretory leukocyte protease inhibitor (SLPI) from the gastrointestinal tract in man.
Nyström M; Bergenfeldt M; Ohlsson K
Scand J Clin Lab Invest; 1997 Apr; 57(2):119-25. PubMed ID: 9200270
[TBL] [Abstract][Full Text] [Related]
2. Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.
Bergenfeldt M; Nyström M; Bohe M; Lindström C; Polling A; Ohlsson K
J Gastroenterol; 1996 Feb; 31(1):18-23. PubMed ID: 8808424
[TBL] [Abstract][Full Text] [Related]
3. The elimination of secretory leukocyte protease inhibitor (SLPI) after intravenous injection in dog and man.
Bergenfeldt M; Björk P; Ohlsson K
Scand J Clin Lab Invest; 1990 Nov; 50(7):729-37. PubMed ID: 2293334
[TBL] [Abstract][Full Text] [Related]
4. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
5. Secretory leucocyte protease inhibitor in the male genital tract: PSA-induced proteolytic processing in human semen and tissue localization.
Ohlsson K; Bjartell A; Lilja H
J Androl; 1995; 16(1):64-74. PubMed ID: 7539415
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and distribution of recombinant secretory leukocyte proteinase inhibitor in rats.
Gast A; Anderson W; Probst A; Nick H; Thompson RC; Eisenberg SP; Schnebli H
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):889-94. PubMed ID: 2327652
[TBL] [Abstract][Full Text] [Related]
7. Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis.
Shimoya K; Moriyama A; Ogata I; Nobunaga T; Koyama M; Azuma C; Murata Y
Mol Hum Reprod; 2000 Sep; 6(9):829-34. PubMed ID: 10956555
[TBL] [Abstract][Full Text] [Related]
8. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.
Moriyama A; Shimoya K; Ogata I; Kimura T; Nakamura T; Wada H; Ohashi K; Azuma C; Saji F; Murata Y
Mol Hum Reprod; 1999 Jul; 5(7):656-61. PubMed ID: 10381821
[TBL] [Abstract][Full Text] [Related]
9. Identification of SLPI (secretory leukocyte protease inhibitor) in human mast cells using immunohistochemistry and in situ hybridisation.
Westin U; Polling A; Ljungkrantz I; Ohlsson K
Biol Chem; 1999 Apr; 380(4):489-93. PubMed ID: 10355635
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of mast cell chymases by secretory leukocyte protease inhibitor.
Pemberton AD; Huntley JF; Miller HR
Biochim Biophys Acta; 1998 Jan; 1379(1):29-34. PubMed ID: 9468329
[TBL] [Abstract][Full Text] [Related]
11. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
Kouchi I; Yasuoka S; Ueda Y; Ogura T
Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
[TBL] [Abstract][Full Text] [Related]
12. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor.
Draper D; Donohoe W; Mortimer L; Heine RP
J Infect Dis; 1998 Sep; 178(3):815-9. PubMed ID: 9728551
[TBL] [Abstract][Full Text] [Related]
13. Salivary concentration of secretory leukocyte protease inhibitor, an antimicrobial protein, is decreased with advanced age.
Shugars DC; Watkins CA; Cowen HJ
Gerontology; 2001; 47(5):246-53. PubMed ID: 11490143
[TBL] [Abstract][Full Text] [Related]
14. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
[TBL] [Abstract][Full Text] [Related]
15. Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role.
King AE; Critchley HO; Kelly RW
Mol Hum Reprod; 2000 Feb; 6(2):191-6. PubMed ID: 10655462
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
[TBL] [Abstract][Full Text] [Related]
17. Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis.
Cox SW; Rodriguez-Gonzalez EM; Booth V; Eley BM
J Periodontal Res; 2006 Oct; 41(5):477-85. PubMed ID: 16953825
[TBL] [Abstract][Full Text] [Related]
18. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
Skott P; Lucht E; Ehnlund M; Björling E
Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
[TBL] [Abstract][Full Text] [Related]
20. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma.
Fath MA; Wu X; Hileman RE; Linhardt RJ; Kashem MA; Nelson RM; Wright CD; Abraham WM
J Biol Chem; 1998 May; 273(22):13563-9. PubMed ID: 9593692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
